Inventor · disambiguated record
Der-Yang Cho
Also filed as: CHO DER-YANG
16 granted patents·11 pending applications·7 citations·filing 2015–2025
86Inventor score
Files withUNIV CHINA MEDICAL13UNIV MEDICAL HOSPITAL CHINA10SHINE ON BIOMEDICAL CO LTD2CHINA MEDICAL UNIVERSITY HOSPITAL1EVER SUPREME BIO TECH CO LTD1
Top patents by PatentIndex Score
27 records- 0189US10988733B2Methods for obtaining pluripotent adult olfactory stem cells from an olfactory mucosa tissueUNIV CHINA MEDICAL·Filed 2020·Granted Apr 27, 2021·2 cites·3 claims
- 0287US11795224B2Anti-T-cell nanobody and nucleic acid encoding sequence thereof, and uses of the sameUNIV MEDICAL HOSPITAL CHINA·Filed 2022·Granted Oct 24, 2023·1 cites·9 claims
- 0376US10696945B2Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem cellsUNIV CHINA MEDICAL·Filed 2017·Granted Jun 30, 2020·1 cites·2 claims
- 0472US12221483B1Fusion protein and nucleic acid encoding sequence thereof, and uses of the sameUNIV MEDICAL HOSPITAL CHINA·Filed 2024·Granted Feb 11, 2025·0 cites·11 claims
- 0569US11685784B2Anti-immune-checkpoint nanobody and nucleic acid encoding sequence thereof, and uses of the sameUNIV MEDICAL HOSPITAL CHINA·Filed 2022·Granted Jun 27, 2023·0 cites·19 claims
- 0668US12319729B1Anti-Staphylococcus aureus specific antibody and nucleic acid encoding sequence thereof, and uses of the sameUNIV MEDICAL HOSPITAL CHINA·Filed 2024·Granted Jun 3, 2025·0 cites·9 claims
- 0768US12012454B2Anti-tumor antigen nanobody and nucleic acid encoding sequence thereof, and uses of the sameUNIV MEDICAL HOSPITAL CHINA·Filed 2022·Granted Jun 18, 2024·0 cites·17 claims
- 0866US2025009929A1Cell repair-promoting extracellular vesicle, production method, preparation, and use thereofUNIV CHINA MEDICAL·Filed 2024·Application pending·0 cites
- 0965US2025336524A1Method for assessing bacteremia and bacteremia assessing systemUNIV CHINA MEDICAL·Filed 2024·Application pending·0 cites
- 1064US2024269077A1Solution for preserving extracellular vesicles/exosomes, method for preserving the same, and mixed solution thereofUNIV CHINA MEDICAL·Filed 2024·Application pending·0 cites
- 1162US2024374726A1Bag6 specific chimeric antigen receptor, nucleic acid, bag6 specific chimeric antigen receptor expression plasmid, bag6 specific chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancerUNIV MEDICAL HOSPITAL CHINA·Filed 2024·Application pending·0 cites
- 1262US2025057973A1Exosomes for treating glioblastoma multiforme and manufacturing method thereofUNIV CHINA MEDICAL·Filed 2024·Application pending·0 cites
- 1359US2022415447A1Method for assessing drug-resistant microorganism and drug-resistant microorganism assessing systemUNIV CHINA MEDICAL·Filed 2022·Application pending·0 cites
- 1458US11969727B2Tumor microenvironment on chipUNIV CHINA MEDICAL·Filed 2021·Granted Apr 30, 2024·0 cites·6 claims
- 1556US11352655B2Method of identification of methicillin-resistant Staphylococcus aureusUNIV MEDICAL HOSPITAL CHINA·Filed 2021·Granted Jun 7, 2022·0 cites·8 claims
- 1656US2024287570A1Method for assessing drug-resistant stenotrophomonas maltophilia and drug-resistant stenotrophomonas maltophilia assessing systemUNIV CHINA MEDICAL·Filed 2023·Application pending·0 cites
- 1755US2024068006A1Method for assessing drug-resistant klebsiella pneumoniae and drug-resistant klebsiella pneumoniae assessing systemUNIV CHINA MEDICAL·Filed 2023·Application pending·0 cites
- 1854US12509519B2Multispecific single domain antibodies chimeric antigen receptor and T-cell engager, nucleic acid, expressing cell thereof, pharmaceutical composition for treating cancer, and method for inhibiting proliferation of tumor cellEVER SUPREME BIO TECH CO LTD·Filed 2022·Granted Dec 30, 2025·0 cites·15 claims
- 1951US11795227B2Immunomodulation and anti-tumor-related nanobody and nucleic acid encoding sequence thereof, and uses of the sameSHINE ON BIOMEDICAL CO LTD·Filed 2022·Granted Oct 24, 2023·0 cites·13 claims
- 2051US11554140B2Nucleic acid, chimeric antigen receptor expression plasmid, chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancerUNIV MEDICAL HOSPITAL CHINA·Filed 2019·Granted Jan 17, 2023·0 cites·5 claims
- 2150USD1007520SDisplay screen or portion thereof with graphical user interfaceUNIV CHINA MEDICAL·Filed 2021·Granted Dec 12, 2023·3 cites·1 claims
- 2248US11479611B2HLA-G specific chimeric antigen receptor, nucleic acid, HLA-G specific chimeric antigen receptor expression plasmid, HLA-G specific chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancerUNIV MEDICAL HOSPITAL CHINA·Filed 2020·Granted Oct 25, 2022·0 cites·16 claims
- 2343US10036751B2Method of evaluating glioblastoma multiforme patient applicable to immunotherapy treatment based on dendritic cell tumor vaccines and method of prognosticating survival rate in glioblastoma mulztiforme patient after treatmentUNIV MEDICAL HOSPITAL CHINA·Filed 2016·Granted Jul 31, 2018·0 cites·5 claims
- 2438US2022409122A1Artificial Intelligence Assisted Medical Diagnosis Method For Sepsis And System ThereofUNIV CHINA MEDICAL·Filed 2021·Application pending·0 cites
- 2538US2025302748A1Method for enhancing the efficiency of drug loading into extracellular vesicles and medicinal products thereofSHINE ON BIOMEDICAL CO LTD·Filed 2025·Application pending·0 cites
- 2637US12277926B2Intelligent medical speech automatic recognition method and system thereofUNIV CHINA MEDICAL·Filed 2021·Granted Apr 15, 2025·0 cites·2 claims
- 2735US2016060599A1Dendritic cell tumor vaccine and method for preparing the sameCHINA MEDICAL UNIVERSITY HOSPITAL·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Der-Yang Cho files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →